Skip to main content
. 2012 May 11;18(5):323–340. doi: 10.1089/ten.teb.2011.0737

FIG. 2.

FIG. 2.

Different strategies for incorporating BPs in scaffolds for bone tissue engineering (a) and (c) or implants (b). Figure 2ci shows the utilization of BPs conjugates to incorporate other drugs into multifunctional scaffolds.7, 32, 34,36,37,40, 134,135,138,139,140,141,147,151,152 CaP, calcium phosphate; PLGA, poly(D,L-lactide-co-glycolide). Color images available online at www.liebertonline.com/teb